# ClinicalTrials.gov record NCT04423211

> PeptideScanner retained ClinicalTrials.gov record NCT04423211 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct04423211-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-06-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04423211-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04423211-leuprolide-v1.json
- Content SHA-256: `071d15b5f5f4490a0d5d7c00b2a73a4484f030086b2f2dfc46fc381a936649af`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04423211 ([`ctg-observation-nct04423211-2026-06-18-6f2cde3ab517`](#source-ctg-observation-nct04423211-2026-06-18-6f2cde3ab517))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04423211 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04423211-2026-06-18-6f2cde3ab517`](#source-ctg-observation-nct04423211-2026-06-18-6f2cde3ab517))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04423211 at 2026-07-30T16:19:03.058Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct04423211-2026-06-18-6f2cde3ab517`](#source-ctg-observation-nct04423211-2026-06-18-6f2cde3ab517))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04423211-2026-06-18-6f2cde3ab517`](#source-ctg-observation-nct04423211-2026-06-18-6f2cde3ab517))

## Sources

<a id="source-ctg-observation-nct04423211-2026-06-18-6f2cde3ab517"></a>
- **ClinicalTrials.gov record NCT04423211 · retained source version 2026-06-18:6f2cde3ab51756553871de9a548a2c0c5338f4078f78ffbe32e5744e249a5c71** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04423211) (`ctg-observation-nct04423211-2026-06-18-6f2cde3ab517`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04423211." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04423211-leuprolide-v1.json SHA-256: 071d15b5f5f4490a0d5d7c00b2a73a4484f030086b2f2dfc46fc381a936649af.